MedTrace Logo

A Study of Metabolic Agents Following Brain Radiation

NCT06150547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2025-08-12

No results posted yet for this study

Summary

This study is being done to determine if CEST magnetic resonance imaging (MRI) and FDG PET are feasible techniques to detect metabolic differences between tumor and brain in patients with a brain tumor.

Conditions

  • CNS Malignancy

Interventions

DIAGNOSTIC_TEST

FDG Positron Emission Tomography

Imaging using an FDG radioactive tracer to look at the head.

DIAGNOSTIC_TEST

Chemical Exchange Saturation Transfer Magnetic Resonance Imaging

A noninvasive diagnostic test for measuring biochemical changes in the brain, especially the presence of tumors.

Sponsors & Collaborators

Principal Investigators

  • Terry C Burns, MD, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-27
Primary Completion
2025-08-04
Completion
2025-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06150547 on ClinicalTrials.gov